superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2016-12-31
- Valid until
- 2017-12-31
- Published
- 2017-02-14
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 9,973,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen operating income: 9,794,000,000 United States dollar", as of 2016-12-31 (until 2017-12-31). Claim clm_9C393580212E, https://asof.is/claim/clm_9C393580212E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815417000004/0000318154-17-000004-index.htm.
APA
AsOf. (2016). Amgen operating income: 9,794,000,000 United States dollar (as of 2016-12-31 (until 2017-12-31)) [Record clm_9C393580212E]. Retrieved November 9, 2026, from https://asof.is/claim/clm_9C393580212E (source: https://www.sec.gov/Archives/edgar/data/318154/000031815417000004/0000318154-17-000004-index.htm)
BibTeX
@misc{asof_clm_9C393580212E,
author = {AsOf},
title = {Amgen operating income: 9,794,000,000 United States dollar},
year = {2016},
howpublished = {\url{https://asof.is/claim/clm_9C393580212E}},
note = {Claim clm\_9C393580212E, as of 2016-12-31 (until 2017-12-31); source: https://www.sec.gov/Archives/edgar/data/318154/000031815417000004/0000318154-17-000004-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_9C393580212E.md/v1/claims/clm_9C393580212Esubmit a correction